MTOR and chronic kidney disease: In CKD, protein kinases such as serine/threonine mammalian target of rapamycin (mTOR) and the AMP-activated protein kinase (AMPK) pathway play a unique role in signal transduction pathways, energy metabolism, inflammation, stress, and cell death in the kidneys [90,91,92].